培美曲塞治疗患者的肾毒性 - Suppr

Suppr

超能文献

Nephrotoxicity in a Patient Treated with Pemetrexed.

作者信息

Zajjari Y, Azizi M, Sbitti Y, El Kabbaj D

机构信息

Department of Nephrology-Dialysis, Military Hospital Mohammed V, Rabat, Morocco.

Department of Oncology, Military Hospital Mohammed V, Rabat, Morocco.

出版信息

Indian J Nephrol. 2017 May-Jun;27(3):243-244. doi: 10.4103/0971-4065.202403.

DOI:10.4103/0971-4065.202403

PMID:28553053

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5434699/

Abstract

摘要

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/de64/5434699/778c740640d4/IJN-27-243-g001.jpg

相似文献

Nephrotoxicity in a Patient Treated with Pemetrexed.培美曲塞治疗患者的肾毒性

Indian J Nephrol. 2017 May-Jun;27(3):243-244. doi: 10.4103/0971-4065.202403.

[Pemetrexed nephrotoxicity].[培美曲塞肾毒性]

Bull Cancer. 2015 Feb;102(2):190-7. doi: 10.1016/j.bulcan.2014.12.012. Epub 2015 Jan 29.

Pemetrexed-induced acute kidney injury leading to chronic kidney disease.培美曲塞诱导的急性肾损伤导致慢性肾脏病。

Clin Nephrol. 2014 Dec;82(6):402-6. doi: 10.5414/CN107921.

Unusually prolonged pemetrexed cytotoxicity in a patient with a lung adenocarcinoma: a case report.一名肺腺癌患者出现异常延长的培美曲塞细胞毒性：病例报告

J Med Case Rep. 2017 Sep 16;11(1):262. doi: 10.1186/s13256-017-1436-7.

Pemetrexed in head and neck cancer: a systematic review.培美曲塞治疗头颈部肿瘤：系统评价。

Oral Oncol. 2013 Jun;49(6):492-501. doi: 10.1016/j.oraloncology.2013.01.007. Epub 2013 Mar 7.

Renal damage induced by pemetrexed causing drug discontinuation: a case report and review of the literature.培美曲塞引起的导致停药的肾损伤：一例病例报告及文献复习

J Med Case Rep. 2017 Jul 28;11(1):182. doi: 10.1186/s13256-017-1348-6.

Pemetrexed/Carboplatin/Bevacizumab followed by Maintenance Pemetrexed/Bevacizumab in Hispanic Patients with Non-Squamous Non-Small Cell Lung Cancer: Outcomes according to Thymidylate Synthase Expression.培美曲塞/卡铂/贝伐单抗序贯培美曲塞/贝伐单抗维持治疗西班牙裔非鳞状非小细胞肺癌患者：根据胸苷酸合成酶表达的结果

PLoS One. 2016 May 18;11(5):e0154293. doi: 10.1371/journal.pone.0154293. eCollection 2016.

Phase II study of pemetrexed and carboplatin plus bevacizumab with maintenance pemetrexed and bevacizumab as first-line therapy for nonsquamous non-small-cell lung cancer.培美曲塞、卡铂联合贝伐单抗一线治疗非鳞状非小细胞肺癌，继以培美曲塞和贝伐单抗维持治疗的II期研究。

J Clin Oncol. 2009 Jul 10;27(20):3284-9. doi: 10.1200/JCO.2008.20.8181. Epub 2009 May 11.

Pemetrexed-induced acute renal failure, nephrogenic diabetes insipidus, and renal tubular acidosis in a patient with non-small cell lung cancer.培美曲塞致非小细胞肺癌患者急性肾衰竭、肾性尿崩症和肾小管性酸中毒。

Med Oncol. 2006;23(3):419-22. doi: 10.1385/MO:23:3:419.

Retrospective efficacy and safety analyses of erlotinib, pemetrexed, and docetaxel in EGFR-mutation-negative patients with previously treated advanced non-squamous non-small-cell lung cancer.厄洛替尼、培美曲塞和多西他赛在既往接受过治疗的晚期非鳞状非小细胞肺癌EGFR突变阴性患者中的回顾性疗效和安全性分析。

Lung Cancer. 2015 Sep;89(3):301-5. doi: 10.1016/j.lungcan.2015.06.017. Epub 2015 Jun 25.

引用本文的文献

Characterization of renal injury in non-squamous non-small cell lung cancer patients treated with pemetrexed: A single-center retrospective study.培美曲塞治疗非鳞状非小细胞肺癌患者肾损伤的特征：一项单中心回顾性研究。

Thorac Cancer. 2024 Dec;15(35):2474-2485. doi: 10.1111/1759-7714.15470. Epub 2024 Oct 29.

The Nephrotoxicity of Drugs Used in Causal Oncological Therapies.用于因果性肿瘤治疗的药物的肾毒性。

Curr Oncol. 2022 Dec 8;29(12):9681-9694. doi: 10.3390/curroncol29120760.

本文引用的文献

Pemetrexed-induced acute kidney injury leading to chronic kidney disease.培美曲塞诱导的急性肾损伤导致慢性肾脏病。

Clin Nephrol. 2014 Dec;82(6):402-6. doi: 10.5414/CN107921.

Kidney tubular toxicity of maintenance pemetrexed therapy.维持性培美曲塞治疗的肾小管毒性。

Am J Kidney Dis. 2011 Nov;58(5):817-20. doi: 10.1053/j.ajkd.2011.04.030. Epub 2011 Aug 17.

Acute Tubular Necrosis and Interstitial Nephritis during Pemetrexed Therapy.培美曲塞治疗期间的急性肾小管坏死和间质性肾炎。

Case Rep Oncol. 2009 Mar 14;2(1):53-56. doi: 10.1159/000208377.

Interstitial nephritis and nephrogenic diabetes insipidus in a patient treated with pemetrexed.培美曲塞治疗的患者发生间质性肾炎和肾源性尿崩症。

Ren Fail. 2010;32(8):1000-4. doi: 10.3109/0886022X.2010.501930.

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验